Breaking News
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
February 21, 2019 - Overweight, obesity in adolescence associated with increased risk of renal cancer later in life
February 21, 2019 - BGU develops new AI platform for monitoring and predicting ALS progression
February 21, 2019 - Researchers discover a new promising target to improve HIV vaccines
February 21, 2019 - Brief Anesthesia in Infancy Does Not Mar Neurodevelopment
February 21, 2019 - Gaming system helps with autism diagnosis
February 21, 2019 - Heart Disease: Six Things Women Should Know
February 21, 2019 - More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
February 21, 2019 - Researchers explore case studies focused on industries that kill more people than employed
February 21, 2019 - Only half of GP practice buildings are fit for purpose
February 21, 2019 - Intense exercise, fasting and hormones can enhance waste-protein removal, study shows
February 21, 2019 - Scientists can monitor brain activity to predict epileptic seizures few minutes in advance
February 21, 2019 - Study quantifies hepatic and intestinal mRNA expression of Ugt isoforms in rats
February 21, 2019 - ‘Apple-Shaped’ Body? ‘Pear-Shaped’? Your Genes May Tell
February 21, 2019 - Can we repair the brain? The promise of stem cell technologies for treating Parkinson’s disease
February 21, 2019 - Trump Plan To Beat HIV Hits Rough Road In Rural America
February 21, 2019 - PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms
February 21, 2019 - Trump plan to beat HIV hits rough road in rural America
February 21, 2019 - Eating blueberries every day could help decrease blood pressure
February 21, 2019 - ‘No Second Chances’ report calls for new measures to combat cardiovascular disease in Australia
February 21, 2019 - Mayo clinic researchers discuss local case studies of leprosy
February 21, 2019 - Scientists demonstrate key role of salt in allergic immune reactions
February 21, 2019 - Experts propose revising the criteria for diagnosis of Parkinson’s disease
February 21, 2019 - The med student and the machine
February 21, 2019 - Hey, Hey! Ho, Ho! Is Striking For School Nurses The Way To Go?
February 21, 2019 - Latest research encourages children to move out and learn through physical activity
February 21, 2019 - Proper oral hygiene and regular visits to dentist can promote heart health

The Current issue of “The view from here” is concerned with Models

image_pdfDownload PDFimage_print

The excitement of the Football World Cup is now over and we are well into the holiday season. This might be the silly season for the newspaper industry, but we get no such break in the white heat of Drug Discovery as covered by Drug Discovery Today. This month’s offering covers a very diverse field – that of models. We are all familiar with the use of models in our industry, but as with many concepts everybody’s concept differs. That is reflected in our offering this month and I hope you agree that we cover a wide range of “models” ranging from development using modern gene editing tools, to cutting edge in vitro models and animal models that have all shown themselves to be essential in advancing drug development.

 

The first article in this month’s offering is entitled: “Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery”, by Gulzar Ahmad and Mansoor Amiji of The Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston,  USA. In this article, the authors provide insights into how the incredibly powerful editing tool, CRISPR/Cas9, can be used to create in vitro and in vivo models for the drug discovery industry capable of enhancing speed and capacity. The impact of the use of this technique has the real potential of accelerating the identification and validation of high value targets, essential for the move into precision medicine in the future.

 

The second article in the series moves away from the molecular biological arena, to the cell biology world. In particular it highlights a field that is becoming ever more influential, especially in (but not exclusive to) the field of oncology. It is by Miryam Mebarki, Annelise Bennaceur and Laurence Bonhomme-Faivre of the APHP-Hopital Paul Brousse Université, Paris, France and is entitled: “Human cell derived organoids as a new ex vivo model for drug assays in oncology”. It is not many years since the mainstay of screening for compounds for oncology were 2D culture models. I don’t have the space (or time) in this newsletter editorial to debate the pros and cons of 2D versus 3D drug screens, but it is fair to say that in general the more physiologically-relevant the culture system the more likely the hits from it will be relevant to the treatment of the disease in in vivo models. Some of the most exciting developments in compound screening in the past few years has been the practical development of what is essentially an ex vivo model system consisting of a 3D culture of stem cells to produce “organoids” – structures that are effectively phenotypic, replicates of the intended target organ. The article describes the development of the technique, in particular its applications in oncology and indicates the scope and limitations of the approach in preclinical studies.

 

Last, but by no means least, we feature the article by Henrik H. Hansen, Michael Feigh, Sanne S. Veidal, Kristoffer T. Rigbolt, Niels Vrang and Keld Fosgerau of Gubra Aps, Denmark  entitled: “Mouse models of nonalcoholic steatohepatitis in preclinical drug development” In contrast with the other two articles, this one covers a field that is very familiar to everyone within the pharmaceutical industry, which is the in vivo animal model. Although for ethical and economic reasons, there has been pressure to reduce animal usage and to reduce our reliance on animal models, they have endured as the best extrapolation from in vitro to human disease. Whether this will change in the future remains the subject of much debate, it is unlikely that animal models will disappear from the drug discovery project map in the near future, if ever. This particular article deals with mouse models of a disease that is becoming more and more prominent in the Western world, such that it is now the major cause of chronic liver disease. The authors discuss the possible causes and pathogenesis of the disease and those strategies that have been adopted to find agents that may interfere with the process. They go on to describe in some detail the models that have been used to investigate drugs that may prove effective and the current status of trials of compounds intended to treat this disease.

 

 

Steve Carney was born in Liverpool, England and studied Biochemistry at Liverpool University, obtaining a BSc.(Hons) and then read for a PhD on the Biochemistry and Pathology of Connective Tissue Diseases in Manchester University, in the Departments of Medical Biochemistry and Histopathology. On completion of his PhD he moved to the Kennedy Institute of Rheumatology, London, where he worked with Professor Helen Muir FRS and Professor Tim Hardingham, on the biochemistry of experimental Osteoarthritis. He joined Eli Lilly and Co. and held a number of positions in Biology R&D, initially in the Connective Tissue Department, but latterly in the Neuroscience Department. He left Lilly to take up his present position as Managing Editor, Drug Discovery Today, at Elsevier. Currently, he also holds an honorary lectureship in Drug Discovery at the University of Surrey, UK. He has authored over 50 articles in peer-reviewed journals, written several book chapters and has held a number of patents. In the last month, Dr. Carney has extended his television and film portfolio by appearing in the Disney film “Christopher Robin”, a natural progression of his in-demand tenor horn skills that have in the past been seen on national TV in the UK (BBC, ITV, channel 4) and France (France 2) and in TV movies such as Harry Price: Ghost Hunter. Other major developments are in the pipeline, so please watch here for developments.

 

Tagged with:

About author

Related Articles